Quick Answer
FATE THERAPEUTICS INC reported Operating Income of -$147.70 million for fiscal year 2025.
FATE THERAPEUTICS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$147.70M | +29.8% |
| 2024 | -$210.28M | -10.4% |
| 2023 | -$190.51M | +38.2% |
| 2022 | -$308.39M | -42.1% |
| 2021 | -$216.99M | -69.4% |
| 2020 | -$128.09M | -27.2% |
| 2019 | -$100.73M | -50.1% |
| 2018 | -$67.09M | -59.3% |
| 2017 | -$42.12M | -31.8% |
| 2016 | -$31.96M | -15.0% |
| 2015 | -$27.78M | -11.6% |
| 2014 | -$24.90M | -40.9% |
| 2013 | -$17.68M | -30.4% |
| 2012 | -$13.56M | -2.0% |
| 2011 | -$13.29M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$34.73M | +33.7% | +6.0% |
| June 30, 2025 | -$36.97M | +18.0% | +10.4% |
| March 31, 2025 | -$41.28M | +19.2% | +21.2% |
| September 30, 2024 | -$52.38M | -2.1% | -16.2% |
| June 30, 2024 | -$45.08M | +27.9% | +11.7% |
| March 31, 2024 | -$51.07M | -78.6% | +0.4% |
| September 30, 2023 | -$51.28M | +40.6% | +18.0% |
| June 30, 2023 | -$62.56M | +24.7% | -118.8% |
- FATE THERAPEUTICS INC showed an increase of +29.8% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, FATE THERAPEUTICS INC’s operating income has declined by 1011.1% (from -$13.29 million to -$147.70 million).
- The most recent figure is from FATE THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: